Название продукции:7-chloro-5-(pentan-3-yl)pyrazolo[1,5-a]pyrimidine
IUPAC Name:7-chloro-5-(pentan-3-yl)pyrazolo[1,5-a]pyrimidine
- CAS:2416875-06-2
- Молекулярная формула:C11H14ClN3
- Чистота:95%+
- Номер в каталоге:CM1075274
- Молекулярная масса:223.7
Упаковочная единица |
Доступно для заказа |
Цена ($) |
Количество |
Только для использования в НИОКР..
Информация о продукции
- Номер CAS:2416875-06-2
- Молекулярная формула:C11H14ClN3
- Точка плавления:-
- Smiles-код:CCC(CC)C1=NC2=CC=NN2C(Cl)=C1
- Плотность:
- Номер в каталоге:CM1075274
- Молекулярная масса:223.7
- Точка кипения:
- Номер Mdl:
- Хранение:
Category Infos
- Pyrazolopyrimidines
- Pyrazolopyrimidine scaffolds are one of the most important heterocyclic compounds in drug discovery. This scaffold has various biological activities, among which anticancer is an important one.
Column Infos
- KB-0742
- Kronos Bio announces the first patient dosed in an expansion cohort with KB-0742 at a dose of 80mg given on a four-days-on, three-days-off schedule. This expansion cohort is enrolling platinum-resistant patients with high-grade serous ovarian cancer (HGSOC). Many cancers exhibit transcriptional deregulation, often characterized by gene amplifications of MYC family oncogene. Targeting the transcription elongation cofactor, cyclin-dependent kinase 9 (CDK9) has emerged as a therapeutic strategy to disrupt MYC oncogenic activity.
KB-0742 is an oral highly selective CDK9 inhibitor designed for the treatment of patients with MYC-amplified and other transcriptionally addicted relapsed or refractory solid tumors, including ovarian, lung, and triple-negative breast cancers.